Ondansetron ODT 4 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F96W8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,892
Award facts
- Contract value 100% obligated
- $5,891.99 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count) under a firm fixed-price contract valued at $5,891.99, with an ultimate completion date of January 13, 2026. This non-set-aside competitive award was issued on January 12, 2026, with performance taking place at the contractor's location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 through December 2026 that enables the company to deliver a broad spectrum of pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor specializing in providing essential medications and medical commodities to federal agencies, particularly the Department of Defense healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to supply diverse pharmaceutical products ranging from specialty medications to vaccines and medical devices across multiple therapeutic domains. This order for Ondansetron—a commonly used anti-nausea medication in military and veteran healthcare settings—reflects the company's critical role as a primary vendor in the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DR26F96W8?
SPE2DR26F96W8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26F96W8 worth?
The government has obligated $5,892 on SPE2DR26F96W8.
Is contract SPE2DR26F96W8 an order under another contract?
Yes. SPE2DR26F96W8 is a delivery order under SPE2DR25D3505, an indefinite delivery contract.
Was contract SPE2DR26F96W8 competed?
The extent of competition for SPE2DR26F96W8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award